Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 1,215,020 |
|
|||||
| News | (1) | ||||||
| Day High | 50.98 | Low High |
|||||
| Day Low | 48.85 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Apellis Pharmaceuticals Inc | APLS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.93 | 4.03% | 49.86 | 16:30:23 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 50.00 | 48.85 | 50.98 | 49.86 | 47.93 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15,305 | 1,215,020 | US$ 50.06 | US$ 60,826,308 | - | 19.8301 - 94.75 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:17:20 | 1 | US$ 50.16 | USD |
Apellis Pharmaceuticals (APLS) Options Flow Summary
Apellis Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 6.01B | 120.58M | - | 396.59M | -525.63M | -4.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Apellis Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APLS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 47.52 | 50.98 | 46.53 | 48.43 | 1,099,009 | 2.34 | 4.92% |
| 1 Month | 58.66 | 59.91 | 46.40 | 51.90 | 1,197,669 | -8.80 | -15.00% |
| 3 Months | 61.60 | 71.90 | 46.40 | 60.05 | 1,314,835 | -11.74 | -19.06% |
| 6 Months | 47.56 | 73.80 | 41.19 | 58.09 | 1,786,820 | 2.30 | 4.84% |
| 1 Year | 84.95 | 94.75 | 19.8301 | 50.44 | 2,630,791 | -35.09 | -41.31% |
| 3 Years | 44.67 | 94.75 | 19.8301 | 51.30 | 1,733,175 | 5.19 | 11.62% |
| 5 Years | 19.20 | 94.75 | 16.85 | 47.45 | 1,347,229 | 30.66 | 159.69% |
Apellis Pharmaceuticals Description
| Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade. |
